March 21, 2019 One in every two individuals born today will be diagnosed with cancer—a genetic disease—at some point during their lifetime. Nick Bellanca of Wamberg Genomic Advisors breaks down
March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to
March 21, 2019 A year after the three corporate giants announced plans to join forces, the ABJ venture unveiled its name: Haven. With 1.2 million covered employees and family members,
March 21, 2019 Rep. Pramila Jayapal’s (D-WA) bill, which calls for a rapid, two-year transition onto a public health plan, is the latest effort to transition the U.S. to a
March 21, 2019 Our Government Affairs team is monitoring bills and action items that would affect the insurance industry. Here’s what we’re focusing on as of late: The “Short on
One in every two individuals born today will be diagnosed with cancer—a genetic disease—at some point during their lifetime. Nick Bellanca of Wamberg Genomic Advisors breaks down their flagship product,
March 15, 2019 The Council’s expert legal team at Steptoe & Johnson created a chart to show the broad landscape of drug pricing legislation in Congress. The chart is updated
February 25, 2019 Our legal team at Steptoe & Johnson is tracking healthcare reform bills as they are introduced in the 116th Congress. Recent updates are noted in the top
The main topic of discussion? How to demonstrate the effectiveness of the employer-sponsored insurance system within a growing national dialogue on government-run healthcare.
The team at NFP resets the dialogue on government-run health systems by exploring how they work in the UK, Canada and here in the U.S. within the Veterans Affairs (VA) program.
